“Biotherapeutic Immunomodulation as a Countermeasure to Hyperinflammatory Tissue Damage
04. June 2015
Related Articles
Presentation and Research Paper presented at the PharmaLunch May, 2015 of the Swiss Academy of Pharmaceutical Sciences in Basel, Switzerland
Steven Taub, Research and Development Manager, Cardiovascular Surgery Department, Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne